COVID-19EmployeesFeatured

Get the facts on the Johnson & Johnson vaccine pause

The Oregon Health Authority explains that federal agencies have halted use of the vaccine while they examine why six women suffered a rare but serious complication.

On April 13, out of an abundance of caution, the U.S. Centers for Disease Control and Prevention and the Food and Drug Administration released a statement recommending a pause in the use of the Johnson & Johnson COVID-19 vaccine immediately while they review data involving six reported U.S. cases of a rare and severe type of blood clot occurring in women age 18–48 after they received the Johnson & Johnson vaccine.

The Oregon Health Authority asked all of the state’s vaccine providers to immediately pause administering the Johnson & Johnson vaccine in accordance with the announcement. [Asante has never administered the Johnson & Johnson vaccine.]

Read the full FAQs from the Oregon Health Authority.

Tags: covid-19, Johnson & Johnson, Oregon Health Authority, pause, vaccine
Asante employees named to state board
Hospital screening process changes for employees

If you have a question, please contact the author or relevant department directly.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.
You need to agree with the terms to proceed

Categories

Popular related content